Search research articles
Contact Us
Filters
Showing results (181-190 of 211) with videos related to
Page
of 22
Sort By:
Bratislavske Lekarske Listy
|
September 29, 2016
Can platelet-rich plasma be used safely in intra-abdominal operations?
F Kaya, K Kismet, H Ozer, et al.
New York State Journal of Medicine
|
December 1, 1985
Clinical significance of serum lactate dehydrogenase in chronic lymphocytic leukemia
T Han, L J Emrich, H Ozer, et al.
Leukemia & Lymphoma
|
July 28, 2016
Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients
H M Golomb, M J Ratain, A Fefer, et al.
Neuro-Oncology Practice
|
August 7, 2019
Correlation of commercially available quantitative <i>MGMT</i> (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival
Laura Dovek, Nhung T Nguyen, Byram H Ozer, et al.
Neuro-Oncology Practice
|
December 29, 2025
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomas
Maria Ioannou, Setu Mehta, Anirudra Devkota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1987
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration
H B Muss, J J Costanzi, R Leavitt, et al.
Archives of General Psychiatry
|
May 1, 1992
Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression
D L Evans, J D Folds, J M Petitto, et al.
Medical and Pediatric Oncology
|
January 1, 1994
Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma
H Ozer, J R Anderson, B A Peterson, et al.
American Journal of Clinical Oncology
|
February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)
S D Luikart, J E Herndon, D R Hollis, et al.
Journal of Neuro-Oncology
|
November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT
Mackenzie Price, Corey Neff, Carol Kruchko, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 211) with videos related to
Sort By:
Page
of 22
Bratislavske Lekarske Listy
|
September 29, 2016
Can platelet-rich plasma be used safely in intra-abdominal operations?
F Kaya, K Kismet, H Ozer, et al.
New York State Journal of Medicine
|
December 1, 1985
Clinical significance of serum lactate dehydrogenase in chronic lymphocytic leukemia
T Han, L J Emrich, H Ozer, et al.
Leukemia & Lymphoma
|
July 28, 2016
Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients
H M Golomb, M J Ratain, A Fefer, et al.
Neuro-Oncology Practice
|
August 7, 2019
Correlation of commercially available quantitative <i>MGMT</i> (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival
Laura Dovek, Nhung T Nguyen, Byram H Ozer, et al.
Neuro-Oncology Practice
|
December 29, 2025
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomas
Maria Ioannou, Setu Mehta, Anirudra Devkota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1987
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration
H B Muss, J J Costanzi, R Leavitt, et al.
Archives of General Psychiatry
|
May 1, 1992
Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression
D L Evans, J D Folds, J M Petitto, et al.
Medical and Pediatric Oncology
|
January 1, 1994
Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma
H Ozer, J R Anderson, B A Peterson, et al.
American Journal of Clinical Oncology
|
February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)
S D Luikart, J E Herndon, D R Hollis, et al.
Journal of Neuro-Oncology
|
November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT
Mackenzie Price, Corey Neff, Carol Kruchko, et al.
Page
of 22